TradingView
RocketTickers
Oct 3, 2018 4:43 PM

Paratek Announces FDA Approval of NUZYRA™ (Omadacycline) Long

NASDAQ:PRTK1D

Description

⋅
PRTK: Paratek Pharmaceuticals, Inc.
2018-10-02 18:37:00
Paratek Announces FDA Approval of NUZYRA™ (Omadacycline)
Beyond Technical Analysis
More